Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome

Brian E Lacy, Nihal K Patel, Brian E Lacy, Nihal K Patel

Abstract

Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the most prevalent, with a worldwide prevalence estimated at 12%. IBS is an important health care concern as it greatly affects patients' quality of life and imposes a significant economic burden to the health care system. Cardinal symptoms of IBS include abdominal pain and altered bowel habits. The absence of abdominal pain makes the diagnosis of IBS untenable. The diagnosis of IBS can be made by performing a careful review of the patient's symptoms, taking a thoughtful history (e.g., diet, medication, medical, surgical, and psychological history), evaluating the patient for the presence of warning signs (e.g., "red flags" of anemia, hematochezia, unintentional weight loss, or a family history of colorectal cancer or inflammatory bowel disease), performing a guided physical examination, and using the Rome IV criteria. The Rome criteria were developed by a panel of international experts in the field of functional gastrointestinal disorders. Although initially developed to guide researchers, these criteria have undergone several revisions with the intent of making them clinically useful and relevant. This monograph provides a brief overview on the development of the Rome criteria, discusses the utility of the Rome IV criteria, and reviews how the criteria can be applied clinically to diagnose IBS. In addition, a diagnostic strategy for the cost-effective diagnosis of IBS will be reviewed.

Keywords: IBS; Rome criteria; irritable bowel syndrome.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Manning A.P., Thompson W.G., Heaton K.W., Morris A.F. Towards positive diagnosis of the irritable bowel. Br. Med. J. 1978;2:653–654. doi: 10.1136/bmj.2.6138.653.
    1. Dang J., Ardila-Hani A., Amichai M.M., Chua K., Pimentel M. Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III. Neurogastroenterol. Motil. 2012;24:853. doi: 10.1111/j.1365-2982.2012.01943.x.
    1. Kruis W., Thieme C., Weinzierl M., Schüssler P., Holl J., Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology. 1984;87:1–7.
    1. Tibble J.A., Sigthorsson G., Foster R., Forgacs I., Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology. 2002;123:450–460. doi: 10.1053/gast.2002.34755.
    1. Thompson W.G., Longstreth G.F., Drossman D.A., Heaton K.W., Irvine E.J., Müller-Lissner S.A. Functional bowel disorders and functional abdominal pain. Gut. 1999;45:II43–II47. doi: 10.1136/gut.45.2008.ii43.
    1. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. doi: 10.1053/j.gastro.2005.11.061.
    1. Ford A.C., Bercik P., Morgan D.G., Bolino C., Pintos-Sanchez M.I., Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145:1262–1270. doi: 10.1053/j.gastro.2013.08.048.
    1. Ford A.C., Lacy B.E., Talley N.J. Irritable Bowel Syndrome. N. Engl. J. Med. 2017;376:2566–2578. doi: 10.1056/NEJMra1607547.
    1. Lacy B.E., Mearin F., Chang L., Chey W.D., Lembo A.J., Simren M., Spiller R. Bowel Disorders. Gastroenterology. 2016;150:1393–1407. doi: 10.1053/j.gastro.2016.02.031.
    1. Spiegel B.M., Bolus R., Agarwal N., Sayuk G., Harris L.A., Lucak S., Esrailian E., Chey W.D., Lembo A., Karsan H., et al. Measuring symptoms in the irritable bowel syndrome: Development of a framework for clinical trials. Aliment. Pharmacol. Ther. 2010;32:1275–1291. doi: 10.1111/j.1365-2036.2010.04464.x.
    1. Palsson O.S., Whitehead W.E., van Tilburg M.A., Chang L., Chey W., Crowell M.D., Keefer L., Lembo A.J., Parkman H.P., Rao S.S., et al. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016 doi: 10.1053/j.gastro.2016.02.014.
    1. Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 1997;32:920–924. doi: 10.3109/00365529709011203.
    1. Chey W.D., Nojkov B., Rubenstein J.H., Dobhan R.R., Greenson J.K., Cash B.D. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: Results from a prospective, controlled US trial. Am. J. Gastroenterol. 2010;105:859–865. doi: 10.1038/ajg.2010.55.
    1. Lacy B.E. The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome. Clin. Gastroenterol. Hepatol. 2015;13:1899–1906. doi: 10.1016/j.cgh.2015.02.043.
    1. Shah S.L., Lacy B.E. Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence. Curr. Gastroenterol. Rep. 2016;18:41. doi: 10.1007/s11894-016-0517-x.
    1. Lacy B.E., Weiser K., Noddin L., Robertson D.J., Crowell M.D., Parratt-Engstrom C., Grau M.V. Irritable bowel syndrome: Patients’ attitudes, concerns and level of knowledge. Aliment. Pharmacol. Ther. 2007;25:1329–1341. doi: 10.1111/j.1365-2036.2007.03328.x.
    1. Linedale E.C., Chur-Hansen A., Mikocka-Walus A., Gibson P.R., Andrews J.M. Uncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disorders. Clin. Gastroenterol. Hepatol. 2016;14:1735–1741. doi: 10.1016/j.cgh.2016.06.030.
    1. Lacy B.E., Moreau J.C. Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations. J. Am. Assoc. Nurse Pract. 2016;28:393–404. doi: 10.1002/2327-6924.12387.
    1. Ford A.C., Quigley E.M., Lacy B.E., Lembo A.J., Saito Y.A., Schiller L.R., Soffer E.E., Spiegel B.M., Moayyedi P. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: Systematic review and meta-analysis. Am. J. Gastroenterol. 2014;109:1350–1365. doi: 10.1038/ajg.2014.148.
    1. Surdea-Blaga T., Baban A., Nedelcu L., Dumitrascu D.L. Psychological Interventions for Irritable Bowel Syndrome. J. Gastrointestin. Liver Dis. 2016;25:359–366.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться